Review
Cholesterol metabolism in neurons and astrocytes

https://doi.org/10.1016/j.plipres.2011.06.002Get rights and content

Abstract

Cells in the mammalian body must accurately maintain their content of cholesterol, which is an essential membrane component and precursor for vital signalling molecules. Outside the brain, cholesterol homeostasis is guaranteed by a lipoprotein shuttle between the liver, intestine and other organs via the blood circulation. Cells inside the brain are cut off from this circuit by the blood–brain barrier and must regulate their cholesterol content in a different manner. Here, we review how this is accomplished by neurons and astrocytes, two cell types of the central nervous system, whose cooperation is essential for normal brain development and function. The key observation is a remarkable cell-specific distribution of proteins that mediate different steps of cholesterol metabolism. This form of metabolic compartmentalization identifies astrocytes as net producers of cholesterol and neurons as consumers with unique means to prevent cholesterol overload. The idea that cholesterol turnover in neurons depends on close cooperation with astrocytes raises new questions that need to be addressed by new experimental approaches to monitor and manipulate cholesterol homeostasis in a cell-specific manner. We conclude that an understanding of cholesterol metabolism in the brain and its role in disease requires a close look at individual cell types.

Introduction

Cholesterol is an indispensible component of biological membranes and precursor to numerous signalling molecules including steroid hormones. Its provision and disposal in all organs of the mammalian body – except for the brain – relies on dietary uptake by the intestine, on de novo synthesis in every organ, and on lipoprotein-mediated transport via the blood circulation. Cells in the brain are cut off from this elaborate system by the blood–brain barrier, which prevents lipoprotein exchange [1], [2]. Therefore, cells in the brain have implemented their specific way to handle cholesterol turnover. Here, we summarize current knowledge of cholesterol metabolism in the central nervous system (CNS) with a focus on two cell types, namely neurons and astrocytes (Fig. 1). Their cooperation is essential for normal brain function, and a disturbance of their interactions can provoke pathologic changes. Complementary overviews focus on cholesterol metabolism in the nervous system [3], [4], [5], [6], [7], [8] and possible links to brain injury and diseases [4], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18].

Section snippets

Neurons and astrocytes: some background

The brain consists of neurons and glial cells. Neurons specialize in the generation and transmission of electrical signals that represent the basis of all brain functions. To accomplish this, they form elaborate processes called axons and dendrites and complex intercellular connections called synapses (Fig. 2). Glial cells, which comprise astrocytes, oligodendrocytes, ependymal and microglial cells, provide structural and logistic support to neurons, which allows them to develop and function

Cell-autonomous supply of cholesterol

All cholesterol contained in the CNS must be formed in situ, because brain cells have no access to the hepatic or dietary supply of cholesterol due to the blood–brain barrier. In general, mammalian cells can synthesize cholesterol from acetyl coenzyme A by a complex series of reactions that are catalyzed by more than 20 enzymes and that require energy and molecular oxygen [54]. In the following, we will describe, whether and how neurons and astrocytes use de novo synthesis to meet their need

External supply of cholesterol

As alternative to de novo synthesis, mammalian cells can import cholesterol from an external source. To this end, providing cells secrete cholesterol as lipoproteins, which are taken up by target cells via specific receptors [83]. The following paragraphs summarize, whether and how neurons and astrocytes use this form of cholesterol provision.

Handling surplus cholesterol

Based on our current knowledge of cholesterol metabolism in neurons and astrocytes, we surmise that only neurons need to deal with cholesterol overload, because they import the component, whereas astrocytes produce cholesterol in excess for its release via APOE-containing lipoproteins.

Conclusion and outlook

The investigation of cholesterol metabolism in the brain has a long history, but it is only within the last decade that this field has gained momentum (Fig. 5), probably because cholesterol is implied in neurodegenerative disease. It is evident that cells in the CNS employ their proper system to maintain their cholesterol content, which is very different from the way cholesterol metabolism is organized in the rest of the body. Our focus on neurons and astrocytes, whose cooperation is necessary

Acknowledgements

The authors gratefully acknowledge previous and ongoing support by Abbott/Laboratoires Fournier, Agence Francaise Contres les Myopathies, Agence National de la Recherche, Ara Parseghian Medical Research Foundation, Centre National de la Recherche Scientifique, Deutsche Forschungsgemeinschaft, ELTEM, European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063), Fondation NRJ-Institut de France, Fondation pour la Recherche Medicale, Max-Planck Society, Merck-Serono,

References (337)

  • F.W. Pfrieger

    Role of glial cells in the formation and maintenance of synapses

    Brain Res Rev

    (2010)
  • G. Perea et al.

    Tripartite synapses: astrocytes process and control synaptic information

    Trends Neurosci

    (2009)
  • M. Santello et al.

    Synaptic modulation by astrocytes via Ca2+-dependent glutamate release

    Neuroscience

    (2009)
  • J. De Keyser et al.

    Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders

    J Neurol Sci

    (2008)
  • J. Wetherington et al.

    Astrocytes in the epileptic brain

    Neuron

    (2008)
  • C. Goritz et al.

    Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron

    Mol Cell Neurosci

    (2005)
  • S. Takamori et al.

    Molecular anatomy of a trafficking organelle

    Cell

    (2006)
  • K. Ogata et al.

    Structural and quantitative analysis of astrocytes in the mouse hippocampus

    Neuroscience

    (2002)
  • C. Serougne-Gautheron et al.

    Time course of biosynthetic cholesterol in the adult rat brain

    Biochim Biophys Acta

    (1973)
  • I. Björkhem et al.

    Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro

    J Biol Chem

    (1997)
  • J.L. Gaylor

    Membrane-bound enzymes of cholesterol synthesis from lanosterol

    Biochem Biophys Res Commun

    (2002)
  • H. Waelsch et al.

    Lipid metabolism in brain during myelination

    J Biol Chem

    (1940)
  • H. Waelsch et al.

    A study of the synthesis and deposition of lipids in brain and other tissues with deuterium as an indicator

    J Biol Chem

    (1940)
  • G. Quan et al.

    Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse

    Brain Res Dev Brain Res

    (2003)
  • K.M. Thelen et al.

    Cholesterol synthesis rate in human hippocampus declines with aging

    Neurosci Lett

    (2006)
  • J. Poirier et al.

    Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats

    Neuroscience

    (1993)
  • H.R. Waterham

    Defects of cholesterol biosynthesis

    FEBS Lett

    (2006)
  • T. Maier et al.

    Correlation of mRNA and protein in complex biological samples

    FEBS Lett

    (2009)
  • J.J. Volpe et al.

    Cholesterol biosynthesis and 3-hydroxy-3-methyl-glutaryl coenzyme A reductase in cultured glial and neuronal cells. Regulation by lipoprotein and by certain free sterols

    Biochim Biophys Acta

    (1977)
  • A.L. Mutka et al.

    Secretion of sterols and the NPC2 protein from primary astrocytes

    J Biol Chem

    (2004)
  • E.I. de Chaves et al.

    Role of lipoproteins in the delivery of lipids to axons during axonal regeneration

    J Biol Chem

    (1997)
  • W.A. Prinz

    Non-vesicular sterol transport in cells

    Prog Lipid Res

    (2007)
  • K. Lorent et al.

    Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40,000 molecular weight receptor-associated protein

    Neuroscience

    (1995)
  • P.C. May et al.

    Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer’s disease and in response to experimental lesions in rat

    Neuron

    (1990)
  • T. Nuutinen et al.

    Clusterin: a forgotten player in Alzheimer’s disease

    Brain Res Rev

    (2009)
  • J.K. Boyles et al.

    Identification, characterization, and tissue distribution of apolipoprotein D in the rat

    J Lipid Res

    (1990)
  • I.A. Haddad et al.

    Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes

    J Biol Chem

    (1986)
  • R.E. Pitas et al.

    Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain

    J Biol Chem

    (1987)
  • E. Rassart et al.

    Apolipoprotein D

    Biochim Biophys Acta

    (2000)
  • M.F. Linton et al.

    Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

    J Clin Invest

    (1991)
  • N. Camargo et al.

    SREBPs: SREBP function in glia–neuron interactions

    FEBS J

    (2009)
  • E.P. De Chaves et al.

    Apolipoprotein E and cholesterol in aging and disease in the brain

    Future Lipidol

    (2008)
  • J.M. Dietschy

    Central nervous system: cholesterol turnover, brain development and neurodegeneration

    Biol Chem

    (2009)
  • M. Mulder

    Sterols in the central nervous system

    Curr Opin Clin Nutr Metab Care

    (2009)
  • D.W. Russell et al.

    Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain

    Annu Rev Biochem

    (2009)
  • Vance JE, Hayashi H. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim...
  • E. Ikonen

    Mechanisms for cellular cholesterol transport: defects and human disease

    Physiol Rev

    (2006)
  • V. Hirsch-Reinshagen et al.

    Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer’s disease

    Curr Opin Lipidol

    (2007)
  • G. Bu

    Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy

    Nat Rev Neurosci

    (2009)
  • I.J. Martins et al.

    Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease

    J Neurochem

    (2009)
  • Cited by (345)

    • The cell biology of APOE in the brain

      2024, Trends in Cell Biology
    • Role of APOE in glaucoma

      2024, Biochemical and Biophysical Research Communications
    View all citing articles on Scopus
    View full text